Log In

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.

Forgot your password?

Don't have an account? Sign Up Here

Join Us

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.

I agree to TheMaven's Terms and Policy

Already have an account? Login here

JIM CRAMER INVESTING PERSONAL FINANCE RETIREMENT TECHNOLOGY MARKETS HOW-TO VIDEO FINANCIAL ADVISOR CENTER

Biotechnology

Inovio Lead

Inovio Pharmaceuticals Vaccine 'Deemed Safe' in Phase I Test

By Rob Lenihan

Regeneron Cholesterol-Lowering Drug Banned From U.S. Market

Kiniksa Reports Positive Results of Pericarditis-Drug Trial

By Dan Weil

As Gilead Mounts a Powerful Rebound, Is a Major Bottom Forming?

Gilead Unveils Pricing For Covid-19 Fighting Remdesivir

ZS Pharma, Gilead & Anacor: BioTech Stock Picks on Sell-Off

Gilead Sciences Says Remdesivir Will Cost $2,340

By M. Corey Goldman

Inovio Lead

Inovio Cut to Hold at Stifel on Valuation, Fundamentals

By Dan Weil

Coronavirus drugs

Vaxart Oral Virus Vaccine Chosen by U.S. for Challenge Study

By Dan Weil

Human Exoskeletons Are Helping Get Stroke and Spinal Cord Victims Walking Again

Ekso Stock Doubles - FDA Widens Marketing OK for Exoskeleton

By Tony Owusu

Moderna Lead

Moderna and Catalent in Deal to Package Covid Vaccine

By Dan Weil

Kroger Shares Resume Trading After Company Misstates Convenience Revenue

These Few S&P 500 Stocks Rose in Wednesday’s Sell-Off

Global Impact Newsletter: A Coronavirus Vaccine And The Return To Normal

Survey: Vaccine Is Far Off, Second Virus Wave Will Hurt, Life Science Execs Say

Coronavirus Lead

Translate Bio Joins With Sanofi to Make Covid-19 Vaccines

By Dan Weil

Eli Lilly Begins to Lift

Eli Lilly Stock Surges - What Do the Charts Say?

By Bret Kenwell

AstraZeneca's Big Bet on Oncology May Finally Pay Off

AstraZeneca Inks Deal to Deliver 400 Million Doses of Potential Vaccine in Europe

By Adam Smith

AbbVie Lead

AbbVie and Genmab Ink $4 Billion Cancer-Treatment Pact

By M. Corey Goldman

Moderna Lead

Why Are Biotech Stocks Surging and How Are They Valued?

Chinese Oil Firm MIE Defaults On US$248 Million Bond After Value Of Its Assets Fall Sharply

Stocks Surge on Cocktail of Tailwinds: What Wall Street’s Saying

Gilead 2

Everything Pushing Stocks Higher Monday

AstraZeneca's Big Bet on Oncology May Finally Pay Off

AstraZeneca Targeted Gilead for Merger: Report

By Adam Smith

Gilead Lead

Gilead Reports Positive Trial Results for Remdesivir

By Dan Weil

Biotech Movers: Lion Biotechnologies, XBiotech, Halozyme

Minerva Schizophrenia-Drug Trial Misses Key Endpoints

By Dan Weil

Stock Gains Accelerate—Vaccine Optimism, Jobless Claims Are Positive Signals

fea nike china covid mask shop retail Robert Way : Shutterstock

Stock Gains Ease Tuesday, But Consumer Stocks Soar

Sanofi Lead

Sanofi Cashes In on Massive Regeneron Stock Run-Up

Covid 19 Vaccine Lead

S&P 500 Breaks Through 3,000 on Novavax Vaccine Optimism

Terms Of Use
Privacy Policy
Advertise
Reprints
Customer Service
Data
Topic Archive
Subscriptions

© 2020 TheStreet, Inc. All rights reserved. Action Alerts PLUS is a registered trademark of TheStreet, Inc.